Consolidated revenues are set to grow by 2x to Rs. 1,5000 crore by 2030; Like-for-like (LFL) RevPar to grow at CAGR of 8%, management income to clock a 15% CAGR and Re-imagined businesses contribution to increase to 25% growing at 30% CAGR over the next five years.
PNB reported 145% y-o-y earnings growth aided by ~92% y-o-y decline in provisions and ~10% y-o-y growth in operating profit resulting in RoA/RoE at 1.0%/ 14.7%.
CESC’s consolidated PAT increased by 1.4% y-o-y to Rs. 353 crore with good performance in Haldia and Dhariwal but it was dragged down by the standalone business and Malegaon DF.
Revenue amounted to Rs. 5,237 crore, reflecting a 20% y-o-y increase but a 16% q-o-q decline, primarily driven by reduced performance in the Indian consumer wellness segment, US formulations and API business.
Order book has reached Rs. 1,050 crore in Q2FY2025 (vs. Rs. 1000 crore in Q1FY2025). Further, management is looking for healthy demand trends in H2FY2025.
Operating profit grew 36% y-o-y to Rs. 278 crore. OPM improved by 176 bps. In line with revenue and operating profit growth adjusted PAT grew 24% y-o-y to Rs. 197 crore against expectation of Rs. 180 crore.
